Cargando…
Precision medicine and drug optimization in adult inflammatory bowel disease patients
Inflammatory bowel diseases (IBD) encompass two main entities including ulcerative colitis and Crohn’s disease. Although having a common global pathophysiological mechanism, IBD patients are characterized by a significant interindividual heterogeneity and may differ by their disease type, disease lo...
Autores principales: | Vieujean, Sophie, Louis, Edouard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184262/ https://www.ncbi.nlm.nih.gov/pubmed/37197397 http://dx.doi.org/10.1177/17562848231173331 |
Ejemplares similares
-
Landscape of new drugs and targets in inflammatory bowel disease
por: Vieujean, Sophie, et al.
Publicado: (2022) -
Precision Medicine in Inflammatory Bowel Disease
por: Annese, Vito, et al.
Publicado: (2023) -
Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models
por: Vieujean, Sophie, et al.
Publicado: (2022) -
Precision Medicine in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2021) -
Precision medicine in inflammatory bowel disease: concept, progress and challenges
por: Borg-Bartolo, Simon P., et al.
Publicado: (2020)